High Times Presents: The U.S. Cannabis Cup


Setback for Sativex

Last week, UK-based GW Pharmaceuticals acknowledged that its cannabis-based oral spray, Sativex, failed a late-stage clinical trial as the experimental drug showed no evidence of reducing pain in cancer patients.

New Marijuana Policy Course at Oregon State University

A new public policy course is changing the face of the curriculum at Oregon State University. Students at the OSU campus in Corvallis, OR will have a chance to help shape policies related to marijuana legalization in Oregon as part of a new sociology course entitled &ldqu...

DC Anti-Pot Campaign Broke the Law Trying to Prevent Legal Weed

A coalition opposing legal cannabis in Washington D.C. was involved in fraudulent activities during its feeble attempt to shut down Initiative 71. A recent report by The DCist indicates that the organization TIE D.C. or Two is Enough, D.C., whose anti-marijuana ...

Study: Long Term Cannabis Exposure Doesn’t Significantly Harm Lungs

The inhalation of one marijuana cigarette per day over a 20-year period is not associated with adverse changes in lung health, according to data published online ahead of print in the journal Annals of the American Thoracic Society.

Colorado Funds Dr. Sisley’s PTSD Study

A team of researchers has received funding from the state of Colorado to launch a long-awaited federal study on the efficacy of marijuana when used to treat patients suffering from Post Traumatic Stress Disorder.



Important notice for Seattle US Cannabis Cup attendees.
A company calling itself High Times Travel LLC (hightimestravel.com) has illegally infringed on the HIGH TIMES trademark to sell travel packages for the upcoming US Cup in Seattle.

This company is not affiliated with HIGH TIMES Magazine in any way. If you have purchased a travel package from High Times Travel LLC please contact HIGH TIMES immediately by emailing us at travelcomplaint@hightimes.com